Taxotere Promotional Efforts Will Focus On Metastatic Breast Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Taxotere promotional efforts regarding metastatic breast cancer use will be a "major field of activity during the months to come in the U.S.," Sanofi-Aventis Exec VP-Pharmaceutical Operations Hanspeter Spek said